Within the treat-to-target approach to identify novel molecular targets in the treatment of IBD, researchers set the focus on specific signal pathways, such as janus kinase/signal transducer and activator of transcription (JAK/STAT) signal cascade. Here, SOAT1 is linked to inflammatory bowel disease.